Impaired host defence mechanisms in intensive care unit patients.
D002056:Burns / Q000276:immunology; D002633:Chemotaxis; D003165:Complement System Proteins / Q000276:immunology; D003920:Diabetes Mellitus / Q000276:immunology; D064420:Drug-Related Side Effects and Adverse Reactions; D005353:Fibronectins / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance; D007136:Immunoglobulins / Q000276:immunology; D007167:Immunotherapy; D007239:Infections / Q000150:complications; D007362:Intensive Care Units; D008104:Liver Cirrhosis, Alcoholic / Q000276:immunology; D009748:Nutrition Disorders / Q000276:immunology; D010586:Phagocytes / Q000276:immunology; D019736:Prostheses and Implants / Q000009:adverse effects; D012306:Risk; D013601:T-Lymphocytes / Q000276:immunology; D014946:Wound Infection / Q000276:immunology; D014949:Wounds, Nonpenetrating / Q000276:immunology
D005353:Fibronectins; D007136:Immunoglobulins; D003165:Complement System Proteins